The study by Nomura et al15 showed moderate PSMA expression in grade I pilocytic astrocytomas (5 patients) and high expression in grade IV glioblastomas (GBM—5 patients), while grade II diffuse (4 patients) and grade III anaplastic (5 patients) astrocytomas were negative. The gene discussed is FOLH1; the disease is glioblastoma.